IBM joins in cancer research, diagnosis

November 9, 2005

The IBM Corp. announced Tuesday it is joining forces with several research centers to help accelerate cancer research, diagnosis and treatment.

IBM, based in Armonk, N.Y., said it will collaborate with the Memorial Sloan-Kettering Cancer Center, the Molecular Profiling Institute and the CHU Sainte-Justine Research Center under separate agreements.

IBM and Sloan-Kettering will build a state-of-the-art integrated information management system to improve the ability of clinicians and researchers to study long-term cancer-related illnesses, identify disease trends and determine success rates.

"This is an excellent multi-sector model that can drive integration of molecular medicine into areas where it's truly needed, including cancer detection, treatment, and ultimately prevention," said Dr. Anna Barker, deputy director of the National Cancer Institute. "The convergence of advanced technologies and post-genomics science will change cancer medicine in ways we cannot yet envision."

Copyright 2005 by United Press International

Explore further: IBM's Watson supercomputer strives to be jack of all trades

Related Stories

Recommended for you

New lizard named after Sir David Attenborough

August 3, 2015

A research team led by Dr Martin Whiting from the Department of Biological Sciences recently discovered a beautifully coloured new species of flat lizard, which they have named Platysaurus attenboroughi, after Sir David Attenborough.

'Snowball earth' might be slushy

August 3, 2015

Imagine a world without liquid water—just solid ice in all directions. It would certainly not be a place that most life forms would like to live.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.